#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18566	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2216	830.6	0	.	n	.	0	C1525T	SNP	1525	1525	C	1733	1733	T	907	T,C	405,425	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18566	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2216	830.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	1058	C,G	982,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18566	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2216	830.6	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1620	1620	T	1041	TGGGGG,TGGGGGG	499,432	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3438	984.5	0	.	n	.	0	T695C	SNP	695	695	T	990	990	C	1043	C	972	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3438	984.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	1933	1933	G	1099	G	1022	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3438	984.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2266	2266	C	1036	C,T	950,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3438	984.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2340	2340	A	1092	A	1036	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	34018	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3438	984.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2892	2892	C	1051	C	995	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2468	folP	855	855	100.0	folP.l15.c4.ctg.1	1563	157.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1027	1029	AGC	240;238;239	A;G;C	221;221;224	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3479	182.0	1	SNP	p	S91F	1	.	.	271	273	TTC	649	651	TTC	219;221;221	T;T;C	195;196;197	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3479	182.0	1	SNP	p	G95N	0	.	.	283	285	GGC	661	663	GGC	218;218;217	G;G;C	193;195;193	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6346	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3479	182.0	1	SNP	p	D95G	1	.	.	283	285	GGC	661	663	GGC	218;218;217	G;G;C	193;195;193	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1994	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1310	150.5	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1017	1019	TTG	196;196;198	T;T;G,T	182;179;180,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1994	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1310	150.5	1	SNP	p	G45D	0	.	.	133	135	GGC	600	602	GGC	247;246;247	G;G;C,A,G	236;234;232,1,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1032	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	983	104.3	0	.	n	.	0	A197.	DEL	197	197	A	533	533	A	263	A	243	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6338	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3067	205.9	1	SNP	p	D86N	0	.	.	256	258	GAC	679	681	GAC	277;277;278	G;A;C	259;255;259	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6338	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3067	205.9	1	SNP	p	S87R	1	.	.	259	261	CGT	682	684	CGT	278;279;279	C;G;T	260;260;256	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6338	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3067	205.9	1	SNP	p	R87W	0	.	.	259	261	CGT	682	684	CGT	278;279;279	C;G;T	260;260;256	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6338	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3067	205.9	1	SNP	p	R87I	0	.	.	259	261	CGT	682	684	CGT	278;279;279	C;G;T	260;260;256	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6338	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3067	205.9	1	SNP	p	S88P	0	.	.	262	264	TCC	685	687	TCC	282;285;287	T;C;C	260;268;271	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5236	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2571	202.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1553	1555	GGC	249;249;244	G;G;C	231;227;225	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1324	1326	GCA	235;236;238	G;C;A	221;221;223	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1327	1329	ATC	237;236;235	A;T;C	222;224;220	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1339	1341	GTG	225;221;222	G,A;T;G	209,1;204;206	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1339	1341	GTG	225;221;222	G,A;T;G	209,1;204;206	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1843	1845	ACC	272;272;270	A;C;C,T	243;245;245,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1897	1899	GCG	256;254;255	G;C,T;G	227;201,1;214	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1897	1899	GCG	256;254;255	G;C,T;G	227;201,1;214	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2020	2022	AGC	211;209;210	A,G;G;C,T	197,1;193;194,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2029	2031	GGC	214;209;205	G,A;G;C	195,1;192;186	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4832	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2425	198.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2047	2049	CCG	192;193;192	C,G,A;C,G;G	138,7,1;138,1;143	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7008	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3101	225.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1615	1617	CCG	246;246;247	C;C;G	223;229;227	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2694	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1858	144.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	561	561	C	191	C	172	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	496	498	GAA	280;281;278	G;A;A	266;266;264	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	784	786	GAT	305;303;302	G,A;A;T	284,1;284;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	907	909	TCA	275;274;276	T;C;A	256;252;257	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1036	1038	GTC	285;285;284	G;T;C	255;247;256	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1048	1050	TCT	297;296;298	T;C;T	275;276;278	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1366	1368	GCA	290;292;291	G,A;C,A;A	270,1;270,1;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	1	SNP	p	G120K	1	.	.	358	360	AAG	742	744	AAG	285;288;292	A;A;G	265;267;269	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	1	SNP	p	A121D	1	.	.	361	363	GAC	745	747	GAC	291;294;295	G;A;C	268;269;273	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3502	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1566	221.8	1	SNP	p	D121N	0	.	.	361	363	GAC	745	747	GAC	291;294;295	G;A;C	268;269;273	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13154	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4960	264.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1438	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	946	150.0	1	SNP	p	V57M	1	.	.	169	171	ATG	464	466	ATG	296;292;293	A;T;G	276;271;271	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
